Navigation Links
Talecris Biotherapeutics Announces First Quarter 2011 Results
Date:4/27/2011

fluctuations in the international markets in which Talecris operates; the impact of the company's substantial capital plan; and other risks identified in the company's most recent filing on Form 10-Q and in the company's Annual Report on Form 10-K for the year ended December 31, 2010 filed with the Securities and Exchange Commission (SEC) on February 23, 2011 (2010 Form 10-K) all of which are available on the company's website.  Talecris undertakes no duty to update any forward-looking statement.

ExhibitsMatters Affecting Comparability (Exhibit A)

Non-GAAP Financial Measures (Exhibit B)

About Talecris Biotherapeutics: Inspiration. Dedication. Innovation.Talecris Biotherapeutics is a global biotherapeutic and biotechnology company that discovers, develops and produces critical care treatments for people with life-threatening disorders in a variety of therapeutic areas including immunology, pulmonology, neurology, critical care, and hemostasis.

Talecris Biotherapeutics Holdings Corp.Consolidated Income Statements(in thousands, except per share amounts)(Unaudited) Three Months Ended March 31, 20112010Net revenue:Product$  398,980$  374,615Other7,6836,346Total406,663380,961Cost of goods sold233,619217,351Gross profit173,044163,610Operating expenses:Selling, general, and administrative62,71767,620Research and development16,53216,271Total79,24983,891Income from operations93,79579,719Other non-operating (expense) income:Interest expense, net(10,750)(11,263)Equity in earnings of affiliate151147Total(10,599)(11,116)Income before income taxes83,19668,603Provision for income taxes(27,739)(23,264)Net income$
55,457$
45,339Net income per common share:Basic$
.44$
.37Diluted$
.43$
.35Talecris Biotherapeutics Holdings Corp.Consolidated Balance Sheets(in thousands, except share and per share amounts) (Unaudited)March 31,December 31,20112010AssetsCurrent assets:Cash and cash equi
'/>"/>

SOURCE Talecris Biotherapeutics Holdings Corp.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. CSL Limited and Talecris Biotherapeutics Agree to Terminate Merger Agreement
2. The Alpha-1 Foundation Awards Two Research Grants with Support from Talecris Biotherapeutics, Inc.
3. Live Webinar: Paperless QC Micro Implemented by Talecris Biotherapeutics
4. Siemens/Talecris Win Best Partnership in the Outsourcing Excellence Awards
5. Talecris Biotherapeutics to Report First Quarter 2010 Financial Results
6. Talecris Biotherapeutics to Present at the Bank of America Merrill Lynch Health Care Conference
7. Talecris Added to NASDAQ Biotechnology Index
8. Talecris Biotherapeutics to Present at the 2010 Citi Investment Research Global Health Care Conference
9. Talecris Names John Perkins as Executive Vice President, Global Commercial Operations
10. Lafmin Morgan Joins Talecris Biotherapeutics as Vice President, U.S. Product Management
11. Talecris Biotherapeutics Announces Premerger HSR Filing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)...   First published articles now ... Elsevier , a world-leading provider of scientific, technical and medical ... of the latest title in the Current Opinion journal ... . Current Opinion in ... to keep up-to-date with the expanding volume of information published ...
(Date:11/24/2014)... Continental Clinical Solutions, LLC (Continental) focuses ... at its mid-Atlantic late-phase research facility, located in ... the idea of closing patient disparities in mind. ... advances," said Continental's CEO, Saleh Stevens . ... cell line of Henrietta Lacks, dubious ethical practices ...
(Date:11/24/2014)... Nov. 24, 2014  Spherix Incorporated (Nasdaq: ... to the fostering and monetization of intellectual property, ... Telecommunications Ltd.,  Case No. 3:13-cv-03494-M and  Spherix v. ... both in the United States District Court for ... . On November 21, 2014 ...
(Date:11/22/2014)... Two new educational webinars hosted by ... ALS research and how the pharmaceutical industry can make life ... Challenge: Where Does the ALS Money Go? , Featuring guest ... Time: 1:30pm ET, Register to attend , This ... Cudkowicz, Julianne Dorn Professor of Neurology at Massachusetts General Hospital ...
Breaking Biology Technology:Elsevier Announces Launch of New Journal: Current Opinion in Food Science 2Elsevier Announces Launch of New Journal: Current Opinion in Food Science 3At Continental Clinical Solutions, CEO Saleh Stevens Focuses on Diversity in Clinical Trial Recruitment at Maryland Site 2At Continental Clinical Solutions, CEO Saleh Stevens Focuses on Diversity in Clinical Trial Recruitment at Maryland Site 3Markman Hearing Held as Scheduled in VTech and Uniden Cases 2DrugDev Webinars in December to Explore What Comes Next for ALS Research and How We Can Make Life Easier for Clinical Sites 2
... 3 Sangamo BioSciences, Inc. (Nasdaq: SGMO ) announced ... an update on the progress of Sangamo,s ZFP Therapeutic(TM) development ... 2:20 pm ET on Tuesday, November 10, 2009 at the ... held in New York City. , The presentation will be ...
... Delaware, November 3 The new market research,report, ... - 2014),published by MarketsandMarkets ( http://www.marketsandmarkets.com ) analyzes,the ... It identifies and analyzes,the main market drivers, restraints, ... applications submarkets in different,geographic regions. , ...
... ... firm Full Spectrum Software announces key hire. Cindy Larkin has been hired as ... experience to her new role. , ... Southborough, MA (Vocus) November 3, 2009 -- Leading medical device and ...
Cached Biology Technology:Sangamo BioSciences Announces Presentation at Merriman Curhan Ford's Investor Summit 2009 2MarketsandMarkets: Global Stem Cell and Advanced Technologies Market Worth US$ 88.3 Billion By 2014 2MarketsandMarkets: Global Stem Cell and Advanced Technologies Market Worth US$ 88.3 Billion By 2014 3Medical Device Software Engineering Firm Full Spectrum Software Appoints Cindy Larkin to Director of Client Services 2
(Date:11/5/2014)... Brazil -Individuals show great diversity in their ability to ... females greatly differ in their perceptual evaluation of odors, ... tests. , Sex differences in olfactory detection ... may be connected to one,s perception of smell, which ... women,s olfactory superiority has been suggested to be cognitive ...
(Date:11/4/2014)... nature, the right amount of death at the right ... according to new research that could help in understanding ... stocks. , In a paper in the journal ... researcher and European colleagues conclude that the kind of ... loss of individuals, or mortality, depends on the size ...
(Date:11/4/2014)... GABLES, Fla. (November 4, 2014) — Think about the ... ask: How do neighboring cells know that they are ... and how do these tissues find the correct place ... are answering these crucial questions. , In a new ... use to communicate with their surrounding neighbors, at the ...
Breaking Biology News(10 mins):The female nose always knows: Do women have more olfactory neurons? 2When less is more: Death in moderation boosts population density in nature 2The inside story: How the brain and skull stay together 2
... made major discoveries that could lead to new treatments for ... team located key molecules that switch on stress pathways in ... these pathways were blocked with a pain drug, lung damage ... online ahead of print in the March issue of ...
... A new wonder material that can generate hydrogen, produce ... Hardly, and there,s more - It can also desalinate ... recover energy from desalination waste brine, be made into ... of lithium ion batteries. With its superior bacteria-killing capabilities, ...
... 20, 2013, John Wiley & Sons, Inc., has renewed ... a partnership which began over sixty years ago. Wiley ... Physiologia Plantarum , an international thought leader in ... in 1948 when the society, known then as the ...
Cached Biology News:Researchers spot molecular control switch for preterm lung disorders 2NTU scientist develops a multi-purpose wonder material to tackle enviromental challenges 2NTU scientist develops a multi-purpose wonder material to tackle enviromental challenges 3NTU scientist develops a multi-purpose wonder material to tackle enviromental challenges 4The Scandinavian Plant Physiology Society and Wiley extend over 60 years of partnership 2
... The c-Jun proto-oncogene was first identified as the ... oncogene. Jun B and Jun D have been ... their C-terminal regions, which are involved in dimerization ... are involved in transcriptional activation, diverge. ...
...
... JAK2 (phospho Y1007) ( Abpromise ... Antigen: Synthesized phosphopeptide derived ... site of tyrosine 1007 (K-E-Y P ... ID: 3717 ...
... eBioscience Intracellular (IC) Fixation Buffer, ... Buffer (Cat. No. 00-8333), can be ... prior to performing intracellular staining of ... antigens. These solutions have been specially ...
Biology Products: